Sessa Capital IM, L.P.

Q2 2021 13F-HR Holdings

Location
New York, NY
Holdings as of
6/30/2021
Date filed
8/16/2021
Form type
13F-HR
Num holdings
61
Total value ($000)
$2,665,823
Net value change ($000)
+70,796 (2.7%)
New positions
28
Sold out positions
1
Turnover %
24.2%
Sector allocation + QoQ delta (equities-only)
Prev filing: 5/17/2021 Next filing: 11/15/2021 SEC filing

Snapshot: Change Analysis

Compared to Q1 2021
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
DTE 136,080 NEW
CC 61,164 24.7%
T 59,971 NEW
GTX 55,159 NEW
EXE 53,529 2123.3%
Provention Bio, Inc. 23,494 NEW
ALLO 19,560 NEW
WW 12,219 15.5%
bluebird bio, Inc. 11,995 45.5%
Volta Inc. 10,211 NEW
Top Reduces (Value $000, Stocks/ETFs)
DD -57,778 -100.0%
CTVA -35,969 -18.3%
AXTA -32,037 -65.6%
EQH -20,697 -12.8%
WFC -17,410 -8.0%
NVT -17,268 -56.2%
PCG -5,005 -13.2%
GLPG -672 -10.6%
XERIS PHARMACEUTICALS INC -515 -3.3%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 834,703 (31.3% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type